Gamida Cell Ltd.
Gamida Cell Ltd. (GMDA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GMDA · as of Jun 9, 2026
Key Statistics
Explore Gamida Cell Ltd. Data
gmda stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 87.5%
Competitors & Peers
gmda competitorsGMDA
APTO
BCEL
CYTO
GRTS
HILSStock Performance
Full HistoryAbout Gamida Cell Ltd.
Gamida Cell Ltd. operates as a clinical-stage biopharmaceutical firm, dedicated to pioneering cell therapies aimed at eradicating blood cancers and other severe hematological conditions. The company's…
what is gamida cell ltd. · gmda stock overview · gamida cell ltd. company profile · who is gamida cell ltd. ceo · gmda NASDAQ · gamida cell ltd. headquarters · gamida cell ltd. business segments
About Stock Overview & Key Data
Gamida Cell Ltd. (GMDA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 26, 2018. As of the latest trading session, GMDA stock price is $0.03, with a market capitalization of $4.3M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Gamida Cell Ltd. stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, Gamida Cell Ltd. reported revenue of $1.8M and net income of -$63.0M. For detailed data — including Gamida Cell Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Gamida Cell Ltd. (GMDA) stock price is $0.03. The stock is traded on NASDAQ under the ticker symbol GMDA. The 52-week range is $0.03 – $0.04.